Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

MORGAN STANLEY M&A Activity 2018

May 22, 2018

29766_rns_2018-05-22_11bef391-5469-4f93-be2d-a6d9d975fa52.html

M&A Activity

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 8675O

Morgan Stanley

22 May 2018

FORM 8.5 (EPT/NON-RI)

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY AN

EXEMPT PRINCIPAL TRADER WITHOUT RECOGNISED INTERMEDIARY ("RI") STATUS (OR WHERE RI STATUS IS NOT APPLICABLE)

Rule 8.5 of the Takeover Code (the "Code")

1.         KEY INFORMATION

(a) Name of exempt principal trader: Morgan Stanley MUFG Securities Co., Ltd.
(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

     Use a separate form for each offeror/offeree
Takeda Pharmaceutical Company Limited
(c) Name of the party to the offer with which exempt principal trader is connected: Shire plc
(d) Date position held/dealing undertaken:

     For an opening position disclosure, state the latest practicable date prior to the disclosure
21 MAY 2018
(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to the offer?

     If it is a cash offer or possible cash offer, state "N/A"
YES - Shire plc

2.         POSITIONS OF THE EXEMPT PRINCIPAL TRADER                            

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a)        Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security: Ordinary
Interests Short positions
Number % Number %
(1) Relevant securities owned and/or controlled: 3,950,332 0.51 4,735,942 0.61
(2) Cash-settled derivatives: 4,550,858 0.58 3,700,582 0.47
(3) Stock-settled derivatives (including options) and agreements to purchase/sell: 0 0.00 0 0.00
TOTAL: 8,501,190 1.09 8,436,524 1.08

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b)        Rights to subscribe for new securities (including directors' and other employee options)

Class of relevant security in relation to which subscription right exists: N/A
Details, including nature of the rights concerned and relevant percentages: N/A

3.         DEALINGS (IF ANY) BY THE EXEMPT PRINCIPAL TRADER

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a)        Purchases and sales

Class of relevant security Purchases/sales Total   number of securities Highest price per unit paid/received Lowest price per unit paid/received
Ordinary PURCHASES 592,155 4,690.0000 JPY 4,625.0000 JPY
Ordinary SALES 507,910 4,691.0000 JPY 4,625.0000 JPY

(b)        Cash-settled derivative transactions

Class of relevant security Product description

            e.g. CFD
Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position
Number of reference securities Price per unit
Ordinary CFD SHORT 9700 4646.5463 JPY
Ordinary CFD LONG 800 4684.1250 JPY
Ordinary CFD SHORT 200 4680.0000 JPY
Ordinary CFD SHORT 18600 4629.9408 JPY
Ordinary CFD SHORT 1400 4668.0714 JPY
Ordinary CFD LONG 399500 4690.0000 JPY
Ordinary CFD SHORT 399500 4690.0000 JPY
Ordinary CFD SHORT 200 4638.5.000 JPY
Ordinary CFD SHORT 3900 4638.2051 JPY
Ordinary CFD LONG 2100 4677.9047 JPY
Ordinary CFD SHORT 1200 4674.7500 JPY
Ordinary CFD SHORT 3700 4630.0000 JPY
Ordinary CFD LONG 2500 4684.0000 JPY
Ordinary CFD LONG 200 4630.7500 JPY
Ordinary CFD LONG 2400 4684.0000 JPY
Ordinary CFD LONG 3500 4630.0000 JPY
Ordinary CFD SHORT 2900 4635.1206 JPY
Ordinary CFD LONG 2248 4690.0000 JPY
Ordinary CFD SHORT 2248 4690.0000 JPY
Ordinary CFD LONG 5600 4684.0000 JPY
Ordinary CFD SHORT 22200 4631.2505 JPY
Ordinary CFD SHORT 21300 4631.2505 JPY
Ordinary CFD SHORT 27900 4666.4675 JPY
Ordinary CFD LONG 1800 4632.4444 JPY
Ordinary CFD SHORT 800 4684.0000 JPY
Ordinary CFD SHORT 1400 4630.4285 JPY
Ordinary CFD SHORT 2100 4646.4761 JPY
Ordinary CFD LONG 17400 4671.3335 JPY
Ordinary CFD LONG 2800 4662.9642 JPY
Ordinary CFD SHORT 4300 4653.3023 JPY
Ordinary CFD SHORT 200 4631.0000 JPY
Ordinary CFD LONG 7200 4630.0000 JPY
Ordinary CFD SHORT 7200 4630.0000 JPY
Ordinary CFD LONG 7200 4630.0000 JPY
Ordinary CFD LONG 27800 4652.3100 JPY
Ordinary CFD SHORT 7200 4672.6944 JPY
Ordinary CFD SHORT 300 4690.0000 JPY
Ordinary CFD LONG 1400 4648.4210 JPY
Ordinary CFD LONG 500 4648.4210 JPY
Ordinary CFD LONG 37755 4682.8152 JPY

(c)       Stock-settled derivative transactions (including options)               

(i)         Writing, selling, purchasing or varying

Class of relevant security Product description e.g. call option Writing, purchasing, selling, varying etc. Number of securities to which option relates Exercise price per unit Type

e.g. American, European etc.
Expiry date Option money paid/ received per unit
N/A N/A N/A N/A N/A N/A N/A N/A

(ii)        Exercise

Class of relevant security Product description

e.g. call option
Exercising/ exercised against Number of securities Exercise price per unit
N/A N/A N/A N/A N/A

(d)        Other dealings (including subscribing for new securities)

Class of relevant security Nature of dealing

e.g. subscription, conversion
Details Price per unit (if applicable)
N/A N/A N/A N/A

4.         OTHER INFORMATION

(a)        Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included.  If there are no such agreements, arrangements or understandings, state "none"
None

(b)        Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i)  the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"
None

(c)        Attachments

Is a Supplemental Form 8 (Open Positions) attached? NO
###### Date of disclosure: 22 MAY 2018
###### Contact name: Craig Horsley
###### Telephone number: +44(141) 245 7736

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at [email protected].  The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

FEOEANSAAEAPEEF